Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 231, pseudogene (RNU6-231P)
- Target
- RNU6-231P
- Molecular classification
- Pseudogene, Non-coding RNA (derived from snRNA gene)
01
Overview
RNU6-231P is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene. U6 snRNA is a key spliceosomal RNA with an essential role in nuclear pre-mRNA splicing, but pseudogenes such as RNU6-231P are non-functional DNA sequences generated by retrotransposition events. These pseudogenes do not produce functional RNA or protein and serve primarily as evolutionary relics or molecular markers of retrotransposition dynamics. RNU6-231P and related U6 snRNA pseudogenes lack biological activity, are not involved in disease processes, and are not considered drug targets. Their main scientific interest is in studies of genomic architecture and evolutionary biology[2][3].
- Other names
- RNU6-231PRNA, U6 small nuclear 231, pseudogene
02
Mechanism of action
None
03
Biological functions
Pseudogenes generally lack known biological functions. Their only role may be in genome architecture or as molecular markers for retrotransposition activity.
04
Disease associations
No established role in disease; U6 snRNA pseudogenes are sometimes studied for their utility as markers of retrotransposition. There is no evidence of direct involvement in cancer, inflammation, neurodegeneration, cardiovascular disease, or infection.
05
Biomarkers
Markers of retrotransposition activity and genomic evolution (not for clinical patient selection or efficacy monitoring)
Beyond the preview
Go deeper on RNA, U6 small nuclear 231, pseudogene (RNU6-231P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 231, pseudogene (RNU6-231P).